Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility
| Brand name | DOPAMINE HYDROCHLORIDE |
| Generic name | DOPAMINE HYDROCHLORIDE |
| Active ingredient(s) | DOPAMINE HYDROCHLORIDE |
| Distributed by / for | Hospira, Inc., Lake Forest, IL 60045 USA, Vial |
| NDC | 0409-5820-11 |
| Full product label | Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01. |
| Recalling firm | Pfizer |
| Distribution | US Nationwide. |
| Quantity | N/A |
| Recall initiated | 2026-09-04 |
| Report date | 2026-09-23 |
| Recall completed | — |
| Recall number | D-0853-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Manhattan NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗